st. marianna university school of medicineigakukai.marianna-u.ac.jp/idaishi/www/353/05-35-03manae...
TRANSCRIPT
� � ����������Vol. 35, pp. 143�149, 2007
���������� ��������������
���
���
��
��
�1 �
�
�
��
��1 �
��
�
���1
��
��
���
��1
��
��
����
1�2
�� :�� 19� 8� 27��
�������� �����
���� ����� ����� ����� !"#$%&'()� ��*+,)-���.�,�/.��0123.�456$� 7��689'�:;4<=�� �>�/+?@A�.B�$CD�:�<=9� E�� -���. !*+,)� �/FG"HI$#4F �embryonic stem, ES� G"�3JK� �LM$�L��.G"# N%&89O'(P)QLR2� 7*$+S.TU<V+SWXHI$Y,'()Z[2\\=9�123. N%&R2I]^�/G"Q_`�/
*ab*�-(� c LA�.T#89I&*$�_`�/*+,)]^�/G"*c /.d0#ef89dgh�Q�:i<=9� bj*$� ES G"�31(.�/G"k. N%&#ZlUm*$2n*dg34G"k. N#5l1'$�o6&9� (�( N%&#�,p7<ZlUm*$c Lh�dgQ%&R2q� _`�/k.�-7�r.st'L9� 1.uv4#B889I&*� 1(.�/G"'$9* in vitro <dg#%&(� 1(.�/G"'m[w)]^891'<]^�/G"Q:;'89d0/#<xRw91'Q:�*L9� dg34G"# N%&(]^89I&*� :;L]^G"y#z&={4*>|� -�Rw9dg./0}?83=@:�'~�329� in vitro<dg34G"# N%&89Um� �. ��A
�(LA�#�B891'Q:;'L9Q� 12$2n* N%&#C�9t�*\,).D�V:;'L9� 1.1'$� �E�4G". N%&LM;*dgh�#FHL�2�,�L,Um*� �.�����#D�(� +S�Gk'�@\�9�V:�'L9���$� ���+?@������. ES G"�3JKG"� �G"� �EG"� d�G"LM# N%&(� 56������*]^891'*?��HA�I�[2IA�QB�891'#J�()�I1�7�� K*JKG"���"���.%&*+,)$� y�L.MN< Np7#P)(),9Q� O����� ES G"#�� ��¡¢D891'< N%&(IJKG"*P£� JK N*¤;LQ¥t� Mash1 ¦R�#&S891'< N%&(IJKG"<$� �H��"��.§T7$�oL9Q;*dg.h�$�oL91'Q �¨),91�2����$123.JKG"#TUV������*]^(� P©Wª'()XY<=9�D«¬.|#ZS(ITUV���''V*Kn(*UV[.�HA�#P)(IKXQ=9� JKG"]^���<$Wª���*P©()\®*�HA�QB�(� ]^¯ 1��]<^o_°L���.�HA�. 50�]`H<B�(I� (�(±^*B�89*$,I3L,1�3�� 1.]^���.�d0#functional MRI <²³(I� ´µ[��a�<$�¶Wª���?�d0$<x(),9V..� _°���?�$d0/Q�r(),93�� 1.I&�JKG"'dg#}�89G"'#9�* N%&(m[w)]^891'*?�� dgh�#b·(
1 ���������� c¸��dµHA�2 ������������¹ ef��º»¼g-���º»*h
143
17
������������� ���� ����������������������������� ES!�"#$%�&� IGFII'%���(� �()*+,!�� -�*,���(�./(),��012�� �345�6� ���7�8�()9:���;<����=�>�?@5�=� AB<�����CDB��(E�5�� F�GH �IJ"!��K�34(���LM5NO� ;<���PQ����=&��RS��012�� �TU� Mash1��!�34()GH � VW�XY�B�IZ[=\E]� ��?@��^���F6=_��4��`�NO� �IA�I��!a� ��b���cde�B� ��Ofghig�Ajkl�k,mn� o�B��pED�B� ES !qo�r �()�I��!a� �=s�t����&��
ES ������������
�u!6�IJ"!Bvw�x!�&��y�Iz! �hemangioblast� qo�r5�8�10���I�{"B�I{" �vasculogenesis�� �IZ[ �angiogenesis�� a(���{"�|}�I�"~6�01��� �arteriogenesis� � 3 �����oN�11� 12�� ���B�[ 17 ��������� �!"����� F��y�Iz!=�H()�#���=7oN� ���!B�uz!6E<� ���!=�I��!6E�� F��I��!=$H(���I��{"5���=� ����I{"���6E�� a���IZ[����B%zA���;<;<�Q!qE�I&={"N� ����01�������B�����'�"~�I�{"=��N�� F�;c��I��!B�I%[�����qo�(�E5!�&
� 1 �� ES !���2 2¡g ¢)�;£ OP9!6v*+()!�{�A, B ��2 2¡g ¢)� 4���¤¡¥g�¦5� *+§�,¨(�-©.�/E!=L[(�ª0«�� *+y��1¬{�!=�N��20«��C, D ��2 2¡g ¢) 4�� OP9!6v*+��( 24K®��¤¡¥g�{��¦5�1¬{�!�20«���/E!=¯<°}�ª0«�{�¤¡¥g=±²³oN� �C�� F��/E!B3E¤¡¥g��/E!64´�µH(�I¶�{"5�·¸�5Q) �D�� �BOP9!�¹�¦5�
ªº»6¼ 7%8% o144
18
�� ��������� ��� ������������������������ ��!"#$�%&'(&)�&*+,-�� .�/012�3456 ES ��7, Flk-1 89��':;-� ������<=��6"#� >?@� ����A�!6���B'CD-@��13�15�� E�FG ES ��7,H� ��!�������=��6"#'CD-@��16�17�� ?7? ES ��7,"#?�I6��&��JK5LM�NO?��PQR�S�TU�VWXY-@�)��
ES ����������� ����������������������� �!"
Z[5\5]^1 �MC��_��`ab;cde�� ��f6��6"#�gh_�,-@���
i��/01 ES ���Z[5\5]^1j�@cd$�%&���� �k��l��2�3������6"#��m�� n:;��op?@qrspcd?�/01 ES ���� 0�8�Z[5\5]^1�tucv!cd�wx$�&� 3yz{��|}96��'~�?� 4yz�� 1�2�6��7,)��^G�6�]�^�b�$��# 1 A, B�����cvjE��%6|}��6�����b!� ��b6��':;?��?@h�6'� ,-� %-'��f�:;?���&*+,-�7��%-� op�op /01��6��1G]^/��!�� OP9���! 24���cd$�&� ��]�^6��6��'��;$����� � ��b6�����;?���'�u���)�]�^6b�'� ,-��# 1C�� FG!� � 17 y�
# 2 �k��l��2�3�������¡�):¢/^£^6��A, B Z[5\5]^1¤¥¦ 4yz �A� 2�3>6¦ OP9��&�cd 24��¦ �B� 6�]�^�2�@� �k��l��6/^£^!�� Flk-16���� ��C, D OP9 ��&�cd 24 ��¦6�]�^�2�@� ������6/^£^!�� CD31 �C� & VE-cadherin �D� 6���� �� VE-cadherin ����]�^§�6��)��<�¨�b�?����©h��$����� ��
/01ª9«����������2�3=��6:;"# 145
19
����������� ��� ���������������� ����������� !�"#$%&� '()� !&�*+,-��./ !��0� .)123�� !&��� !����4��56,7 !�"#$%&� ���������"#$%189,7�:;�����<=>7� ?7���*+,7 !�@)&� AB1CD1-EF,�GHI;��,7�� 1D�� JKLM1NB-��./ !&AB1OF,-PQ��R;������ ��LM1S>756�TU�.VW�-B��XYZ�7�<+56,7 !1��./?7&[ !1\]^�<_`%a%�Jb,-B�=� RT-PCR cNdefghi1-jk,7� ����� !�`%a%�XYZ�� Flk-1&18�� `lm ES !&Jb,-NZn� opqrq#%mst !Ndeopqrq#%mstu OP9�vwxu,7 !1Jb;yz7�� 1�� {|� ES !&opqrq#%m�wx��������� !1<+56������}~��7�I�� !���./ !Jb��� CD34
& ES !�opqrq#%mstu� !� OP9�vwxu� !1Jb;yz7� ��./�`%a%&� VE-cadherin& Flk-1����Jb;},7�� CD31& ES !=ZJb;yz7�$"p���rpq"����� �nicotinicacethylcholine receptor, nAChR� & a� a� b� g ?7& e� d ����$��=Z�� 5 ���0���./ !1NB- a7;�� nAChR ���1d0���K�������������719��nAChR �Jb; a1�7� b1�4������1�B-jk,7���� a2Nde b1�Jb;opqrq#%mst !Ndeopqrq#%mstuOP9 !�vwx,7 !1yz7� ���K;���� Est-120�� Vezf-121�����K;����Hex22��Jb Flk-1 ���1yz7�� Est-1 &OP9 ! Jb;yz7�¡¢�£¢;¤¥��<_¦H�,-� ���§p#¨�©ª%«�� erythropoietin producing
human hepatocellular carcinoma�Eph� �¬���®� Ephrin �Eph-receptor-interacting protein��¨m¯°�±²��� EphrinB2 &¡¢./ !1Jb,-N023�� @³£¢./ !1& EphB4
� 1 ��H� !\]^�<_� mRNA �Jb
´µ¶·¸ ¹_º_ Z146
20
���������24�� �� � �� �������������� ��������� !��� "�#�$%�&�� �'()*$+,-25�� .���/�&0��1 EphrinB2� EphB4 2�34�,� �� ��� 5,�670���/+,�82�����-9&� ��670����+,�0���:�;��<=� Tie2 1�ES 0�� >?@A@BCDE�0�� >?@A@BCDE�F OP90�2GH�&0�����34�,&� 670�I��J+,� PDGF1$%�&��K$�L��0�!MN��:O�PQ!�R�� 8� PDGF � B S�>?@A@BCDE�0�� >?@A@BCDE�F OP90�2GH�&0�T���34�,&� ���UV0��WCXC2-� aSMA ���1� OP90�!YZ[�0��\���34�,&� >?@A@BCDE��]^�_��0���/+,Q�82�`a+,�� bcde@���!f���T ghi!j9&�� >?@A@BCDE�0�� Flk-1���!34� >?@A@BCDE�F OP90�2GH�&0����670��WCXCTk� VE-cadherin� CD31����34�,&�� 2��8,��$l��� >?@A@BCDE�\mnOP9 0�2�GH�mo�p��q0�\mn��670���0���/TQ�82�`a+,&� rF8�0�s�R� +��tuvw�<O�x�yzt*I!;{O�2G�� 8,��0�!|}� ~1 3��H�mo��!*����������� �6T����*�vtu!���Q&� �� ES 0����/�&��0�v��V0�2G���@�����O�82�mo� ��������������� ������K$+,�����2��m'->X���T��O���� � ����de@(T���-�9&tu����M��mo�tu���O��!��O���Tk��
����
.��8,(T�W�D!�&����� ES0���w�/�&���0�����8,(T��-����� ¡�¢���Tk�82�`+,&� 82���tuv��V�tu���1£ ���Tk9&� ���-��� ES 0��1¤
K¥��!1�4� �¦§�!�¨O©�� ªo«¬j�-,®-�-¯°�±� ���-¯°��²�O�³��k��.�1´���¦§�!�¨�� rF�³�-µ¶���!·¸¹º)��Tk��
� �
1� Chiba S, Ikeda R, Kurokawa MS, YoshikawaH, Takeno M, Nagafuchi H, Tadokoro M,
Sekino H, Hashimoto T and Suzuki N. Ana-
tomical and functional recovery by embryonic
stem cell-derived neural tissue of a mouse
model of brain damage. J Neurol Sci 2004; 219:
107�117.2� Ikeda R, Kurokawa MS, Chiba S, YoshikawaH, Hashimoto T, Tadokoro M and Suzuki N.
Transplantation of motoneurons derived from
MASH1-transfected mouse ES cells reconsti-
tutes neural networks and improves motor
function in hemiplegic mice. Exp neurol 2004;
189: 280�292.3� Ikeda R, Kurokawa MS, Chiba S, YoshikawaH, Ide M, Tadokoro M, Nito S, Nakatsuji N,
Kondoh Y, Nagata K, Hashimoto T and
Suzuki N. Transplantation of neural cells de-
rived from retinoic acid-treated cynomolgus
monkey embryonic stem cells successfully im-
proved motor function of hemiplegic mice with
experimental brain injury. Neurobiol Dis 2005;
20: 38�48.4� Hamada M, Yoshikawa H, Ueda Y, Kuro-kawa MS, Watanabe K, Sakakibara M, Ta-
dokoro M, Akashi K, Aoki H and Suzuki N.
Introduction of the MASH1 gene into mouse
embryonic stem cells leads to di#erentiation of
motoneuron precursors lacking Nogo receptor
expression that can be applicable for transplan-
tation to spinal cord injury. Neurobiol Dis
2006; 22: 509�522.5� Kamochi H, Kurokawa MS, Yoshikawa H,Ueda Y, Masuda C, Takada E, Watanabe K,
Sakakibara M, Natuki Y, Kimura K, Beppu
M, Aoki H and Suzuki N. Transplantation of
myocyte precursors derived from embryonic
W�D�»¼0�����670�\mn�0��w�/ 147
21
stem cells transfected with IGFII gene in a
mouse model of muscle injury. Transplanta-
tion 2006; 82: 516�526.6� Homma R, Yoshikawa H, Takeno M, Kuro-kawa MS, Masuda C, Takada E, Tsubota K,
Ueno S and Suzuki N. Induction of epithelial
progenitors in vitro from mouse embryonic
stem cells and application for reconstruction of
damaged cornea in mice. Invest Pohthalmol
Vis Sci 2004; 45: 4320�4326.7� Miyagi T, Takeno M, Nagafuchi H, TakahashiM and Suzuki N. Flk1� cells derived frommouse embryonic stem cells reconstitute hema-
topoiesis in vivo in SCID mice. Exp Hematol
2002; 30: 1444�1453.8� Keller G, Kennedy M, Papayannopoulou Tand Wiles MV. Hematopoietic commitment
during embryonic stem cell di#erentiation in
culture. Mol Cell Biol 1993; 13: 473�486.9� Kennedy M, Firpo M, Choi K, Wall C, Rob-ertson S, Kabrun N and Keller G. A common
precursor for primitive erythropoiesis and de-
finitive haematopoiesis. Nature 1997; 386: 488�493.
10� Park C, Ma YD and Choi K. Evidence for thehemangioblast. Exp Hematol 2005; 33: 965�970.
11� Risau W. Mechanisms of angiogenesis. Nature1997; 386: 671�674.
12� Buschmann I and Schaper W. The pathophysi-ology of the collateral circulation �arteriogene-sis�. J Pathol 2000; 190: 338�342.
13� Hirashima M, Kataoka H, Nishikawa S, Mat-suyoshi N and Nishikawa S. Maturation of
embryonic stem cells into endothelial cells in an
in vitro model of vasculogenesis. Blood 1999;
93: 1253�1263.14� Yamashita J, Itoh H, Hirashima M, Ogawa M,
Nishikawa S, Yurugi T, Naito M, Nakao K
and Nishikawa S. Flk1-positive cells derived
from embryonic stem cells serve as vascular
progenitors. Nature 2000; 408: 92�96.15� Sone M, Itoh H, Yamashita J, Yurugi-
Kobayashi T, Suzuki Y, Kondo Y, Nonoguchi
A, Sawada N, Yamahara K, Miyashita K,
Park K, Shibuya M, Nito S, Nishikawa S and
Nakao K. Di#erent di#erentiation kinetics of
vascular progenitor cells in primate and mouse
embryonic stem cells. Circulation 2003; 107:
2085�2088.16� Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J and Langer R. Endothelial cells de-
rived from human embryonic stem cells. Proc
Natl Acad Sci USA 2002; 99: 4391�4396.17� Gerecht-Nir S, Ziskind A, Cohen S and Itsko-
vitz-Eldor J. Human embryonic stem cells as
an in vitro model for human vascular develop-
ment and the induction of vascular di#erenti-
ation. Lab Invest 2003; 83: 1811�1820.18� Lugus JJ, Park C and Choi K. Developmentalrelationship between hematopoietic and endo-
thelial cells. Immunol Res 2005; 32: 57�74.19� Heeschen C, Weis M, Aicher A, Dimmeler S
and Cooke JP. A novel angiogenic pathway
mediated by non-neuronal nicotinic acetylcho-
line receptors. J Clin Invest 2002; 110: 527�536.20� Sato Y. Role of ETS family transcription fac-tors in vascular development and angiogenesis.
Cell Struct Funct 2001; 26: 19�24.21� Miyashita H, Kanemura M, Yamazaki T, AbeM and Sato Y. Vascular endothelial zinc finger
1 is involved in the regulation of angiogenesis:
possible contribution of stathmin�OP18 as adownstream target gene. Arterioscler Thromb
Vasc Biol 2004; 24: 878�884.22� Minami T, Murakami T, Horiuchi K, MiuraM, Noguchi T, Miyazaki J, Hamakubo T, Aird
WC and Kodama T. Interaction between hex
and GATA transcription factors in vascular
endothelial cells inhibits flk-1�KDR-mediatedvascular endothelial growth factor signaling. J
Biol Chem 2004; 279: 20626�29635.23� Gerety SS, Wang HU, Chen ZF and Anderson
DJ. Symmetrical mutant phenotypes of the re-
ceptor EphB4 and its specific transmembrane
ligand ephrin-B 2 in cardiovascular develop-
ment. Mol Cell 1999; 4: 403�414.24� Wang HU, Chen ZF and Anderson DJ. Mo-
����� ���� 148
22
lecular distinction and angiogenic interaction
between embryonic arteries and veins revealed
by ephrin-B2 and its receptor Eph-B4. Cell
1998; 93: 741�753�
25� Zhong TP, Childs S, Leu JP and Fishman MC.Gridlock signalling pathway fashions the first
embryonic artery. Nature 2001; 414: 216�220.
���������� �������������� 149
23